Stock Analysis on Net

CVS Health Corp. (NYSE:CVS)

Enterprise Value to FCFF (EV/FCFF)

Microsoft Excel

Free Cash Flow to The Firm (FCFF)

CVS Health Corp., FCFF calculation

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Net income attributable to CVS Health 4,614 8,344 4,149 7,910 7,179
Net (income) loss attributable to noncontrolling interests (28) 24 16 (12) 13
Net noncash charges 4,412 5,043 5,009 6,419 5,514
Change in operating assets and liabilities, net of effects from acquisitions 109 15 7,003 3,948 3,159
Net cash provided by operating activities 9,107 13,426 16,177 18,265 15,865
Interest paid, net of tax1 2,170 1,811 1,657 1,872 2,140
Purchases of property and equipment (2,781) (3,031) (2,727) (2,520) (2,437)
Free cash flow to the firm (FCFF) 8,496 12,206 15,107 17,617 15,568

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

Item Description The company
FCFF Free cash flow to the firm is the cash flow available to the CVS Health Corp. suppliers of capital after all operating expenses have been paid and necessary investments in working and fixed capital have been made. CVS Health Corp. FCFF decreased from 2022 to 2023 and from 2023 to 2024.

Interest Paid, Net of Tax

CVS Health Corp., interest paid, net of tax calculation

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Effective Income Tax Rate (EITR)
EITR1 25.40% 25.10% 26.00% 24.20% 26.30%
Interest Paid, Net of Tax
Interest paid, before tax 2,909 2,418 2,239 2,469 2,904
Less: Interest paid, tax2 739 607 582 597 764
Interest paid, net of tax 2,170 1,811 1,657 1,872 2,140

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 See details »

2 2024 Calculation
Interest paid, tax = Interest paid × EITR
= 2,909 × 25.40% = 739


Enterprise Value to FCFF Ratio, Current

CVS Health Corp., current EV/FCFF calculation, comparison to benchmarks

Microsoft Excel
Selected Financial Data (US$ in millions)
Enterprise value (EV) 141,269
Free cash flow to the firm (FCFF) 8,496
Valuation Ratio
EV/FCFF 16.63
Benchmarks
EV/FCFF, Competitors1
Abbott Laboratories 34.45
Cigna Group 11.57
Elevance Health Inc. 17.18
Intuitive Surgical Inc. 135.70
Medtronic PLC 22.49
UnitedHealth Group Inc. 22.70
EV/FCFF, Sector
Health Care Equipment & Services 22.65
EV/FCFF, Industry
Health Care 22.95

Based on: 10-K (reporting date: 2024-12-31).

1 Click competitor name to see calculations.

If the company EV/FCFF is lower then the EV/FCFF of benchmark then company is relatively undervalued.
Otherwise, if the company EV/FCFF is higher then the EV/FCFF of benchmark then company is relatively overvalued.


Enterprise Value to FCFF Ratio, Historical

CVS Health Corp., historical EV/FCFF calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data (US$ in millions)
Enterprise value (EV)1 135,154 146,035 151,066 181,495 146,595
Free cash flow to the firm (FCFF)2 8,496 12,206 15,107 17,617 15,568
Valuation Ratio
EV/FCFF3 15.91 11.96 10.00 10.30 9.42
Benchmarks
EV/FCFF, Competitors4
Abbott Laboratories 35.21 36.51 23.24 23.47 36.94
Cigna Group 10.77 10.44 13.38 14.17 9.16
Elevance Health Inc. 15.57 14.19 13.32 12.74 6.04
Intuitive Surgical Inc. 153.43 170.92 85.45 56.01 76.70
Medtronic PLC 20.58 26.54 20.32 33.84 21.43
UnitedHealth Group Inc. 20.57 17.59 19.30 22.21 15.82
EV/FCFF, Sector
Health Care Equipment & Services 21.76 18.86 17.40 19.23 15.32
EV/FCFF, Industry
Health Care 22.99 24.06 17.76 17.08 18.03

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 See details »

2 See details »

3 2024 Calculation
EV/FCFF = EV ÷ FCFF
= 135,154 ÷ 8,496 = 15.91

4 Click competitor name to see calculations.

Valuation ratio Description The company
EV/FCFF Enterprise value to free cash flow to the firm is whole company valuation indicator. CVS Health Corp. EV/FCFF ratio increased from 2022 to 2023 and from 2023 to 2024.